BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Drug Development

  Juvaris BioTherapeutics’ Vaccine Adjuvant, JVRS-100, Generates Superior T-Cell Mediated Immune Responses to Influenza in Clinical Trial

  April 27, 2009

   · 

  1 min read
• CEL-SCI Presents Data at Prestigious Medical Conference

  April 27, 2009

   · 

  5 min read
• BioMidwest

  Kraig Biocraft Laboratories, Inc. Clarifies Stock Dividend Record Date and Ex Date

  April 27, 2009

   · 

  1 min read
• Genetown

  Resolvyx Pharmaceuticals, Inc. to Present Data on Novel Resolvin Drug Candidates for Eye Disease at ARVO Annual Meeting

  April 27, 2009

   · 

  1 min read
• Drug Development

  Sepracor, Inc. Reports Preliminary Phase III Study Results for OMNARIS(R) HFA Nasal Aerosol in Seasonal Allergic Rhinitis

  April 27, 2009

   · 

  1 min read
• Business

  Orchid Cellmark to Announce First Quarter 2009 Financial Results on May 7, 2009

  April 27, 2009

   · 

  3 min read
• Policy

  Zynex CEO Responds to Lawsuits

  April 27, 2009

   · 

  1 min read
• BioForest

  Miraculins Inc. Announces Private Placement Offering

  April 27, 2009

   · 

  4 min read
• Business

  NextBio, Merck & Co., Inc. in Licensing Deal

  April 27, 2009

   · 

  1 min read
• Theratechnologies Inc. Presents Additional Data From Studies Evaluating Tesamorelin at the Annual Canadian Conference on HIV/AIDS Research

  April 27, 2009

   · 

  5 min read